The latest report by IMARC Group, titled “Australia Diagnostic Imaging Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033,” offers a comprehensive analysis of the diagnostic imaging growth. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Australia diagnostic imaging market size reached USD 977.20 million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,717.28 million by 2033, exhibiting a growth rate (CAGR) of 5.80% during 2025-2033.
Base Year: 2024
Forecast Years: 2025–2033
Historical Years: 2019–2024
Market Size in 2024: USD 977.20 million
Market Forecast in 2033: USD 1,717.28 million
Market Growth Rate 2025–2033: 5.80%
The Australia diagnostic imaging market is rapidly evolving, driven by continuous advancements in imaging technologies and an increasing aging population. Healthcare providers are adopting innovative modalities like AI-enabled MRI, CT, and ultrasound systems, which are enhancing diagnostic accuracy and workflow efficiency. The rising incidence of chronic diseases is expanding the demand for advanced imaging diagnostics, while government initiatives are facilitating improved healthcare infrastructure and access. Both urban and regional healthcare facilities are investing in portable and standalone imaging solutions to support early disease detection and treatment monitoring. These ongoing developments are propelling market expansion across multiple healthcare segments nationwide.
Request For Sample Report:
https://www.imarcgroup.com/australia-diagnostic-imaging-market/requestsample
****
The market is benefiting from the integration of artificial intelligence and 3D imaging technologies, which are improving image resolution and diagnostic speed. Rising prevalence of cardiovascular diseases, cancers, and neurological disorders is intensifying demand for precise diagnostic tools. Public and private sector investment is increasing for infrastructure upgrades and digital health platforms, such as teleradiology and cloud-based systems, enhancing data sharing and remote patient care. Additionally, government policies promoting healthcare digitization and patient-centric approaches are encouraging widespread adoption of modern imaging technologies. These factors collectively are driving the diagnostic imaging market’s sustained growth in Australia.
****
Request For Sample Report:
https://www.imarcgroup.com/australia-diagnostic-imaging-market
The competitive landscape is witnessing significant movements as Wesfarmers and Macquarie Group vie to acquire I-MED Radiology, Australia’s largest diagnostic imaging provider, in a deal valued at about AUD 3 billion. Managed by Morgan Stanley, the sale process is attracting private equity interest from Bain Capital and others. This acquisition signals consolidation trends and increasing investor confidence in Australia’s healthcare imaging sector. Meanwhile, innovative companies like Micro-X are receiving grants to develop cutting-edge mobile CT scanners, highlighting the market’s push toward technology-driven growth and expanded accessibility.
****
Key highlights of the Report:
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Ask analyst for your customized sample:
https://www.imarcgroup.com/request?type=report&id=33978&flag=E
****
About Us: IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-631-791-1145